IndiaTickerLatest filing: Analysts/Institutional Investor Meet/Con. Call Updates - Eris Lifesciences Limited
ObservedCompany dossier
Eris Lifesciences
NSE:ERIS · ISIN INE406M01024
- Close
- ₹1,426.5 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Eris Lifesciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹727.5 Cr · PAT ₹86.9 Cr.
Exchange XBRLLatest ownership: promoter group 54.14% and public 45.86% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Eris Lifesciences Limited
NSE · conference call
Observed
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE · exchange filing
Observed
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recording
BSE · conference call recording
Observed
Source filing Eris Lifesciences Ltd - 540596 - Financial Results For The Quarter Ended June 30, 2026
BSE · financial results
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹727.5 Cr
- Profit after tax
- ₹86.9 Cr
- EPS
- ₹6.15
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 54.14%
- Public
- 45.86%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL